United Therapeutics

Yahoo Finance • 11 days ago

Alger Russell Innovation Index Updates for Fourth Quarter 2025

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close... Full story

Yahoo Finance • 2 months ago

Assessing United Therapeutics (UTHR) Valuation After Robust Double-Digit Growth and Recent Share Price Surge

United Therapeutics (UTHR) recently posted double-digit annual revenue and net income growth, which has caught the attention of investors who follow financial health. Its performance over the past three months has also outpaced many peers... Full story

Yahoo Finance • 2 months ago

United Therapeutics Q3 2025 Earnings Preview

* United Therapeutics (NASDAQ:UTHR [https://seekingalpha.com/symbol/UTHR]) is scheduled to announce Q3 earnings results on Wednesday, October 29th, before market open. * The consensus EPS Estimate is $7.31 [https://seekingalpha.com/sym... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Gain Late Afternoon

Health care stocks rose late Friday afternoon, with the NYSE Health Care Index and the Health Care S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Rothschild & Co Redburn upgraded Kenvue... Full story

Yahoo Finance • 4 months ago

United Therapeutics Corp (NASDAQ:UTHR): A Prime Value Investing Candidate with Strong Fundamentals

Value investing, a strategy established by Benjamin Graham and famously used by Warren Buffett and Charlie Munger, involves finding stocks trading for less than their intrinsic value. This method looks for companies with good fundamentals... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks edged higher late Friday afternoon with the NYSE Health Care Index edging up 0.1% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Health care stocks advanced Friday afternoon, with the NYSE Health Care Index up 0.2% and the Health PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

MannKind's Plan of Increasing Revenue Base, Advancing Potential Pipeline Enhances its Value Creation, Oppenheimer Says

MannKind's (MNKD) game plan of enhancing its revenue base, while also advancing a potential pipeline PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint

Markets reopened after the Labor Day break on softer footing, with futures tied to the major indexes pointing lower. Investors are balancing several pressures at once: gold prices have surged to fresh record highs above $3,550 an ounce, si... Full story

Yahoo Finance • 4 months ago

Stocks making the biggest midday moves: Frontier Group, Kraft Heinz, Biogen and more

Check out the companies making the biggest moves in midday trading: Frontier Group — Shares of the budget airline carrier shot up more than 13% in the wake of rival Spirit Airlines' bankruptcy filing on Friday. Humana — Shares of the healt... Full story

Yahoo Finance • 4 months ago

Why United Therapeutics Catapulted 38%, Pulling Insmed, Liquidia With It

United Therapeutics stock catapulted Tuesday, pulling shares of rivals Insmed and Liquidia higher, on positive test results in IPF. Continue Reading View Comments... Full story

Yahoo Finance • 4 months ago

Why MannKind (MNKD) Is Up 11.7% After Expanding Technosphere Partnership With United Therapeutics

On August 24, 2025, United Therapeutics announced an amendment to its license and collaboration agreement with MannKind, expanding the deal to cover a new development product formulated using MannKind’s Technosphere platform and triggering... Full story

Yahoo Finance • 4 months ago

MannKind rises as United Therapeutics exercises option for second inhalational drug

[Collaboration concept. Colored threads are connected together and the inscription.] designer491/iStock via Getty Images * MannKind Corporation (NASDAQ:MNKD [https://seekingalpha.com/symbol/MNKD]) added ~10% in the morning hours on Wedn... Full story

Yahoo Finance • 4 months ago

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) --  MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—granted under the companies’ 2018 license and... Full story

Yahoo Finance • 4 months ago

United Therapeutics Corp. (NASDAQ:UTHR) Embodies Peter Lynch's GARP Strategy

In the world of long-term investing, few strategies have shown as much practical success as the approach supported by Peter Lynch. His methodology, detailed in _One Up on Wall Street_, highlights finding companies with solid growth potenti... Full story

Yahoo Finance • 4 months ago

UNITED THERAPEUTICS CORP (NASDAQ:UTHR) – A Prime Value Investment with Strong Fundamentals and Undervalued Potential

Value investing focuses on finding stocks priced below their true worth while having solid financial foundations. The approach, based on Benjamin Graham’s ideas, looks for firms with good earnings, stable finances, and room to grow, but tr... Full story

Yahoo Finance • 5 months ago

UNITED THERAPEUTICS CORP (NASDAQ:UTHR) Excels as a High-Quality Pick in the Caviar Cruise Stock Screen

The Caviar Cruise stock screening strategy is designed to find high-quality companies suitable for long-term investment. Based on quality investing principles, this method looks for firms with steady revenue and profit growth, high returns... Full story

Yahoo Finance • 5 months ago

Why UNITED THERAPEUTICS CORP (NASDAQ:UTHR) Fits Peter Lynch’s Growth at a Reasonable Price (GARP) Strategy

Peter Lynch’s investment strategy, as described in _One Up on Wall Street_, centers on finding companies with steady growth at fair prices, commonly known as the Growth at a Reasonable Price (GARP) method. The approach highlights solid fun... Full story

Yahoo Finance • 5 months ago

United Therapeutics outlines $1B share repurchase and 12% revenue growth while advancing TETON 2 data catalyst

Earnings Call Insights: United Therapeutics (UTHR) Q2 2025 MANAGEMENT VIEW * Martine A. Rothblatt, CEO, highlighted, "United Therapeutics has achieved another record quarter of earnings, marking 12 consecutive quarters of double-digit... Full story